Home / Sell by State / Georgia
Georgia · Sell-Side M&A
Georgia repealed its explicit corporate-practice-of-medicine ban in 1982, but a possible common-law restriction was never cleanly settled. That ambiguity is exactly where Georgia deals are won or lost, because structure is negotiated on every transaction. We represent Georgia owners only, and we build the deal around the rules instead of around the buyer.
A confidential ballpark in under two minutes, no email required.
Georgia's Real Differentiator
Georgia is not a clean permissive state. It repealed its explicit corporate-practice-of-medicine prohibition in 1982 (O.C.G.A. Section 43-34-37), but the Georgia Supreme Court in Sherrer v. Hale signaled a possible surviving common-law restriction against corporate involvement in the learned professions, and no higher Georgia court has squarely re-decided that question since. The doctrine is ambiguous rather than abolished. That single fact is why a Georgia sale is never an off-the-shelf company purchase, and why structure decides whether your deal closes and how it holds up.
To lawfully deliver medicine in Georgia, the clinical entity must be a professional corporation or professional LLC owned by Georgia-licensed physicians. Under Georgia's Professional Corporation Act, only licensed professionals actively practicing in the state may be shareholders of a medical PC.
Because a non-physician buyer cannot own the clinical entity, acquirers use the MSO and friendly-PC structure. A physician owns the PC that holds the clinical license; the buyer's management services organization owns the non-clinical assets and contracts with the PC under a long-term management services agreement.
Management fees have to be set at fair market value to stay defensible under the unsettled doctrine. A fee stream that looks like a disguised purchase of clinical control is exactly what a hostile court or regulator would challenge, so fee design is a structuring decision, not a formality.
Who holds the PC after closing, the management-fee design, and physician-employment and retention terms are all negotiated and lawyer-driven on a Georgia deal. There is no boilerplate. This is the structuring work that moves value and timeline.
The 1982 repeal, the O.C.G.A. Section 43-34-37 citation, and the Sherrer v. Hale common-law signal are reported in a healthcare-law explainer (Permit Health), not quoted here as black-letter statute. Sherrer v. Hale is reported at 285 S.E.2d 714 (Ga. 1982). Verify the exact code subsection on a primary source before relying on it in a transaction. Accurate as of June 2026.
| Measure | Figure | Note |
|---|---|---|
| Georgia population | ~11.3M | Eighth-most populous US state |
| State-level med spa count | Not published | AmSpa reports national totals only |
| Anchor metro | Atlanta | Concentration of practices |
AmSpa's State of the Medical Spa Industry report publishes a national med spa count only and includes no state-by-state breakdown or ranking. Population figure is a US Census Bureau estimate.
Market Reality
Georgia carries a large, active aesthetic and dermatology base. AmSpa's State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable Georgia figure. What is verifiable is scale: Georgia is the eighth-most populous state in the country at roughly 11.3 million residents, anchored by Atlanta. The independent ownership underneath that population base is the consolidation runway you are sitting on, and it is why national platforms keep deploying capital here.
Run my numbers →See Your Number First
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
What lowers your number
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
What Moves Value Here
No Georgia-specific sale multiple is published, and we will not invent one. The honest anchor is the national vertical range already on our med spa, cosmetic dermatology, and plastic surgery hubs. What changes a Georgia seller's realized value is not the headline number, it is how the deal has to be built and how defensibly it clears the state's ambiguous corporate-practice posture.
Because the deal runs through an MSO and friendly-PC wrap, a buyer is paying for the management-fee stream and the durability of the PC relationship, not a clean equity purchase. A cleanly structured practice with fair-market-value fees transacts faster and holds its multiple.
Map my structure →Georgia's unsettled common-law question means buyers price the risk that a structure is later challenged. A defensible MSO design and durable physician retention is what lets a seller hold value through diligence instead of conceding on re-trades.
See the Georgia rules →Georgia is a deep Sunbelt market, and national platforms are actively consolidating here, with capital already deployed in Atlanta. That demand is what supports the national range for a well-prepared seller.
Who is buying →We reference the national vertical multiple range published on our practice-type hubs. We do not publish a Georgia-specific multiple, because none exists in a citable, defensible form. Your real range comes from a confidential, practice-specific analysis of your earnings, your structure, and your comps.
Who Is Actually Buying in Georgia
A Georgia seller does not depend on one local acquirer. Well-capitalized national platforms buy here, and there is a verifiable in-state proof point: Forefront Dermatology, a private-equity-backed national platform acquired by Partners Group in 2022, operates a clinic in Atlanta. National private-equity capital is already deployed in Georgia. We will never name a "local buyer" that does not exist.
Detail bars are redacted by design. Every name and activity claim on this board is published from verifiable records; anything beyond the public record stays confidential. Forefront's Atlanta clinic is the in-state proof point. Partners Group's 2022 acquisition of Forefront from OMERS Private Equity is documented in a Partners Group press release, and the firm reports Forefront operating more than 200 clinics across 22 states. The Atlanta clinic at 5505 Peachtree Dunwoody Rd, Suite 412, is corroborated through third-party directory listings, not quoted from Forefront's own page. The other platforms are named as national consolidators active in the dermatology and aesthetics vertical, per CT Acquisitions and Physician Growth Partners market updates. No local-only buyer is asserted.
Georgia Sale FAQ
Not the clinical side. To deliver medicine in Georgia, the practice has to be a professional corporation or professional LLC owned by Georgia-licensed physicians, so a non-physician investor cannot directly own the clinical entity. The standard path is the MSO and friendly-PC structure: a physician owns the professional corporation that holds the clinical license, while the buyer owns a management services organization that contracts to provide non-clinical business services for a fee. That is why a Georgia sale is a structured transaction, not a simple stock or asset sale.
Georgia repealed its explicit statutory corporate-practice-of-medicine prohibition in 1982 (O.C.G.A. Section 43-34-37). In the same period the Georgia Supreme Court, in Sherrer v. Hale, signaled a possible surviving common-law restriction against corporate involvement in the learned professions, and no higher Georgia court has squarely re-decided the question since. So the doctrine is legally ambiguous rather than cleanly abolished. For a seller, that ambiguity is why deal structure, who holds the professional corporation after closing, the management-fee design, and physician-employment terms are negotiated and lawyer-driven on every transaction, not boilerplate.
No. There is no published Georgia-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how Georgia law and market move structure and value. Because Georgia’s posture is ambiguous, a clean, defensible MSO structure with management fees set at fair market value and durable physician retention is what lets a seller hold value through diligence. A practice that is not structured that way invites re-trading and discounts. Your real number comes from a confidential, practice-specific analysis.
Demand is national, and national capital is already deployed in Georgia. Forefront Dermatology, a private-equity-backed national dermatology and aesthetics platform acquired by Partners Group in 2022, operates a clinic in Atlanta. Other national consolidators active in the broader dermatology and aesthetics vertical include U.S. Dermatology Partners, Pinnacle Dermatology, Anne Arundel Dermatology, Epiphany Dermatology, and Aqua Dermatology. Industry trackers count more than 35 private-equity-backed platforms across roughly 20 states, with buyer concentration in Sunbelt metros that include Atlanta. The accurate picture is well-capitalized national platforms buying in Georgia, not a single local acquirer.
Georgia is a deep, active market anchored by Atlanta. AmSpa’s State of the Medical Spa Industry report publishes a national med spa count only, with no state-by-state breakdown or ranking, so we will not cite an uncitable Georgia figure. What is verifiable is scale: Georgia is the eighth-most populous state in the country, with roughly 11.3 million residents per US Census Bureau estimates. The depth of independent ownership around Atlanta is the consolidation runway a Georgia seller is sitting on.
Yes, unless and until you choose to tell people. We run every process under strict confidentiality, with confidentiality agreements, secure data rooms, staged disclosure, and a vetted buyer process. Premature disclosure can unsettle staff, shake patient confidence, and weaken your negotiating position, so you decide what is shared, with whom, and when. Sell-side-exclusive representation means we work for you alone and never sit on the buyer’s side of your table.
Match Your Practice Type
How recurring and membership revenue, provider capacity, and key-person risk set a med spa's value, paired with the Georgia structure work above.
Med spa sell-side →Where Georgia's national derm buyers are deploying capital, and how a cosmetic derm practice is valued for sale.
Cosmetic derm sell-side →The valuation and deal-structure work for a surgical aesthetic practice, mapped to Georgia's corporate-practice posture.
Plastic surgery sell-side →By Metro
Compare every market on the Sell by State directory.
Atlanta buyer activity and how a Georgia sale is structured for value.
Selling in Atlanta →
Who you work with
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceStart with a confidential, two-minute read on where you stand.
